Dental Equipment & Consumables Market by Product Type, Technology, Material Type, Patient Type, Distribution Channel, End User, Application

List of Tables

The Dental Equipment & Consumables Market was valued at USD 54.28 billion in 2025 and is projected to grow to USD 58.42 billion in 2026, with a CAGR of 8.01%, reaching USD 93.11 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 54.28 billion
Estimated Year [2026]	USD 58.42 billion
Forecast Year [2032]	USD 93.11 billion
CAGR (%)	8.01%

Entering 2025, dental equipment and consumables advance through digital integration, regulatory change, and shifting clinical economics

The dental equipment and consumables landscape enters 2025 with clear momentum toward digital care, tighter regulatory expectations, and a recalibration of practice economics. Chairside imaging, AI-enabled diagnostics, and cloud-first workflows have moved from early adoption to mainstream consideration, while materials science continues to refine the durability and esthetics clinicians can deliver at scale. At the same time, staffing constraints, reimbursement friction, and inflationary inputs keep pressure on margins-intensifying the demand for technologies and processes that improve throughput without trading off quality.

The operating context in the United States is shaped by a persistently tight hygiene and assistant labor market, rising overhead, and cautious capital spending. Dentist surveys at the end of 2024 pointed to staffing as the top challenge through 2025, alongside concerns about reimbursement and the cost of doing business, trends that have continued into the most recent quarters. These dynamics are prompting more disciplined ROI thresholds for equipment purchases and a sharper focus on automation, interoperability, and training that shorten learning curves and unlock productivity earlier in the ownership cycle. Globally, product roadmaps increasingly converge around open, cloud-connected ecosystems that blend imaging, design, and production-whether a practice chooses in-house milling, 3D printing, or lab-centric workflows. At the same time, policy actions in large markets are reshaping product mix and material choices: the European Union's phase-out of dental amalgam takes effect in 2025, and extended MDR transition timelines continue to influence portfolio rationalization and notified-body capacity planning. Together, these forces reward suppliers and care organizations that align technology choices with regulatory foresight and patient expectations for safer, more sustainable, and more esthetic outcomes. From AI-augmented imaging to cloud-native workflows, the industry's most transformative shifts are redefining care delivery and value

The most visible transformation is the maturation of AI-augmented imaging across both 2D radiography and cone-beam CT (CBCT). In 2025, the FDA cleared the first dental AI platform to support both modalities, expanding algorithmic assistance from bitewings and panoramics to 3D anatomical segmentation. Pediatric indications widened the scope further, allowing AI support for early caries detection in children as young as four. These milestones matter because they push AI adoption from niche decision support to everyday chairside utility, where consistency, documentation, and patient communication all benefit. Concurrently, standards and interoperability have taken a step forward. The ADA's informatics initiative has consolidated access to standards and technical reports that developers and providers can use to build more secure, interoperable, and clinically usable systems. This scaffolding reduces integration friction and improves data liquidity between practice management, imaging, planning, and design applications-critical as group practices and DSOs scale multi-site digital workflows. Complementing this, technical guidance on teledentistry is helping practices determine appropriate use cases, architecture, and documentation so virtual touchpoints can augment, rather than fragment, the patient journey. On the hardware side, cloud-native intraoral scanning is changing how offices stand up and scale digital impressions. New systems can scan directly to the cloud from an internet-connected device, enabling distributed teams to collaborate without dedicated workstations and easing IT overhead. Imaging innovation is equally brisk in extraoral modalities: next-generation CBCT units emphasize motion-correction algorithms, ultra-low-dose protocols, and software-embedded AI-features designed to raise diagnostic confidence while protecting patients and staff. Together, these advances compress the time from data capture to case presentation, improving acceptance and experience. Digital ecosystems are also extending into production. Materials companies and printer manufacturers have aligned around chairside 3D-printed permanent restorations, signaling a shift from same-day temporaries to durable indications within validated workflows. Strategic partnerships linking established restorative brands with 3D printing platforms are accelerating this capability and elevating expectations for speed, fit, and longevity in a single visit. Finally, supply and policy signals from adjacent parts of healthcare continue to ripple into dentistry. The EPA's 2024-2025 ethylene oxide actions and monitoring requirements aimed at commercial sterilizers underscore industry-wide commitments to lower emissions and mitigate cancer risk. While most dental instruments are heat-sterilized in-office, many disposable devices and sterile consumables use EtO at contract sterilizers; as these facilities invest to comply, providers should anticipate lead-time variability and plan inventory accordingly. This sits alongside durable CDC and FDA guidance on reprocessing reusable devices and heat-sterilizing handpieces, reinforcing infection-control rigor as the baseline expectation for every practice. How 2025 United States tariffs reshape dental supply costs, sourcing strategies, and practice-level purchasing across care settings

Trade policy is exerting a measurable influence on both consumables and equipment in 2025, and the cumulative effect is reshaping sourcing and purchasing decisions. Several tariff adjustments that originated in 2024 took effect on January 1, 2025, including increased rates on certain tungsten products and on solar wafers and polysilicon. For dentistry, tungsten matters because carbide burs and some instrumentation rely on tungsten inputs; even if finished goods are assembled outside China, tariffed inputs can cascade through cost structures. Meanwhile, semiconductors sourced from China face a higher rate in 2025, intersecting with the electronics intrinsic to digital imaging systems, intraoral scanners, milling machines, and chairside units. In consumables, tariff rates on syringes and needles imported from China rose dramatically in 2024 and remain elevated, while rubber medical and surgical gloves stepped up to higher rates in 2025 with further increases scheduled in 2026. Practices that rely on these items daily-local anesthesia needles, injection syringes, exam gloves, and certain facemasks-are already feeling pass-through effects in ordering budgets. The direction of travel is clear: as tariffs become a persistent feature rather than a temporary shock, distributors and group practices are diversifying suppliers, negotiating multi-year contracts with non-tariffed origins, and investing in demand planning to smooth procurement. Beyond Section 301, 2025 also brought new tariff announcements targeting categories beyond dentistry but with potential indirect effects on healthcare inflation and consumer sentiment. Announced in late September 2025, additional import taxes on selected product classes-most notably pharmaceuticals-contributed to broader uncertainty for provider supply chains that share upstream manufacturing networks with medical and dental products. While legal and implementation details continue to evolve, leadership teams should scenario-plan for price volatility and evaluate clauses in supplier agreements that address tariff-related surcharges. The international context adds nuance. China extended certain tariff exemptions on U.S. goods into early 2025, an action that modestly eased frictions in select categories and highlighted the fluid, reciprocal nature of tariff policy. For dental businesses that export into Asia or source components trans-Pacific, this underscores the value of dual-sourcing and the need to monitor not just U.S. measures but counterpart actions that can alter landed cost and lead time in either direction. Segmentation insights reveal where value concentrates across products, technologies, materials, patients, channels, end users, and applications

Across products, technology, materials, patients, channels, end users, and applications, the market's center of gravity is moving toward integrated, digital, patient-centric solutions. Among product types, consumables maintain their critical role in daily care, while equipment drives step-changes in efficiency and experience. Within consumables, implant, endodontic, and orthodontic categories are evolving in different ways. Implant systems continue to pivot toward surface and connection designs that improve primary stability and prosthetic flexibility, with endosteal implants remaining the dominant platform and subperiosteal alternatives reserved for specific anatomical contexts. Endodontic products reflect an infection-control-first mindset: engine-driven files and broaches designed for safer single-use protocols, obturators optimized for streamlined thermoplasticized techniques, and sealers formulated for bioactivity and postoperative comfort. Orthodontic products-classically brackets and archwires-coexist with the continued expansion of clear aligner therapy; this coexistence pushes metal systems to compete on reduced friction, esthetics, and digital integration with treatment planning.

Equipment strategy is increasingly about diagnostic-to-therapeutic connectivity. Diagnostic systems-from dental lasers used in soft-tissue procedures to digital imaging and intraoral scanning-set the data foundation for faster, more persuasive case presentations. Cloud-native scanning is redefining how teams collaborate and how quickly digital impressions reach labs or chairside design software. General equipment, spanning casting machines, furnaces, model scanners, and milling units, is being reimagined for modularity and serviceability, while therapeutic equipment such as dental chairs, handpieces, and integrated units emphasize infection control, ergonomics, and embedded diagnostics. Recent launches highlight these vectors: cloud-connected scanners that bypass dedicated PCs, and CBCT families that embed motion correction and ultra-low-dose protocols directly into acquisition workflows. Technology preference is shifting decisively toward digital without fully displacing traditional methods. Practices that adopt digital impressions, AI-supported radiographic review, and integrated design software report more confident clinical decisions and improved chairside communication. Yet conventional techniques remain essential as training pathways and backup modalities, especially in settings where capital budgets are constrained or where analog-digital hybrids fit case-mix realities. As AI extends from 2D radiographs into CBCT and pediatric care, the digital value proposition moves beyond convenience to measurable gains in detection consistency and workflow timing. Material selection balances strength, esthetics, biology, and manufacturability. Ceramics-lithium disilicate and multilayer zirconia-anchor fixed restorative choices and continue to be refined through better translucency gradients and processing efficiencies. Metals retain primacy in implant fixtures and instrumentation, with titanium alloys and specialized surface treatments pairing mechanical performance with osseointegration. Polymers-whether high-performance thermoplastics for provisional restorations or printable resins for splints and surgical guides-benefit from tighter process controls and validated post-processing. Biomaterials, including bone grafts and tissue scaffolds, support the growth of implantology and periodontics, aided by improved handling and evidence on regenerative outcomes. In laboratories, new characterization pastes and veneering ceramics are streamlining one-firing finishing while broadening shade and texture realism, reflecting a steady march toward mass-customized esthetics. Patient mix is reshaping demand. Adult patients continue to drive restorative and cosmetic volumes, while geriatrics increase the emphasis on implant-retained restorations, tissue management, and maintenance protocols that accommodate systemic comorbidities. Pediatric care leverages AI-assisted radiographic analysis to support earlier caries detection and parent communication, improving acceptance of preventive and minimally invasive treatments. The common thread across age cohorts is a stronger expectation for comfort, speed, and esthetics, which privileges digital impressions, guided surgery, and same-day solutions. Access pathways are diversifying across distribution channels. Offline distribution remains indispensable for equipment installation, service, and complex solution selling, particularly among full-service distributors and their regional footprints. At the same time, online channels have matured well beyond basic reordering: manufacturer websites now offer direct education and configuration tools, and third-party e-commerce platforms integrated into DSO inventory systems streamline procurement across large practice networks. The combination of direct-to-provider portals and integrated marketplaces gives procurement leaders new levers to manage formulary compliance, price transparency, and real-time availability. End-user environments are differentiating in their technology roadmaps. Dental clinics remain the primary locus of adoption for intraoral scanners and chairside production, while hospitals and ambulatory surgical centers focus on advanced imaging and oral surgery workflows. Academic and research institutes influence purchasing through curriculum updates that increasingly require students to master digital impressions, CBCT review, and AI-assisted diagnostics before graduation. This diffusion of skills and expectations feeds back into hiring criteria, vendor training programs, and service models, aligning product development with workforce realities and the requirements of restorative, endodontic, orthodontic, periodontic, prosthodontic, cosmetic, oral surgery, and restorative applications.

Regional dynamics spotlight divergent adoption curves and policy headwinds across the Americas, Europe-Middle East-Africa, and Asia-Pacific

Regional dynamics illustrate how policy, demography, and installed base shape the trajectory of adoption. In the Americas, U.S. practices are navigating margin pressure from staffing and overhead alongside the opportunity to consolidate gains from digital workflows. Health Policy Institute polling shows staffing remains a primary constraint, even as recruitment has modestly improved from the heights of 2022. Practices are responding with targeted equipment investments tied to clear productivity metrics, broader use of AI for radiographic review and documentation, and closer collaboration with distributors on service uptime and training. As these choices compound, DSOs and multi-location groups are standardizing technology stacks to reduce variation and speed onboarding across sites. Across Europe, the Middle East, and Africa, regulation is the prominent demand shaper. The EU's prohibition on the use and export of dental amalgam from January 1, 2025, is accelerating the shift to resin-based and ceramic alternatives, while transitional provisions under the MDR-extended through 2027-2028 for eligible legacy devices-are influencing portfolio rationalization and notified-body scheduling. Vendors are concentrating filings on devices with the strongest clinical and commercial value propositions, and providers are auditing inventories to ensure continuity for lines transitioning to MDR certificates. In parallel, connected workflows and low-dose imaging remain core to modernization, with manufacturers showcasing motion-correction, dose-optimization, and software-embedded AI at major shows. Asia-Pacific continues to post the most rapid diffusion of digital, albeit unevenly across markets. China's volume-based procurement has lowered implant prices and, despite periodic inventory adjustments, broadened access to implant therapy-creating a larger long-run patient pool for surgical kits, biomaterials, and prosthetics. Japan's aging population sustains demand for implant maintenance and removable prosthetics enhanced by digital workflows, while India and Southeast Asia are fueling growth in aligner therapy and esthetic procedures tied to rising middle-class consumption and dental tourism. Investments in extraoral imaging portfolios and handheld intraoral X-ray devices reflect a regional appetite for high-performance, versatile equipment that balances throughput with safety. Company-level moves and innovations signal competitive focus on digital ecosystems, materials science, and distribution modernization

Recent company moves point to an industry aligning around digital ecosystems, materials innovation, and distribution modernization. In scanning and imaging, new cloud-native intraoral scanners allow direct-to-cloud capture, which, when paired with platform services, simplifies deployment across multi-site organizations. On the CBCT side, expanded product families with motion-correction, ultra-low-dose protocols, and AI-readiness demonstrate a clear focus on diagnostic confidence, safety, and uptime in busy practices. AI has become a competitive axis in its own right. With the first FDA clearance for 3D dental radiologic AI atop existing 2D indications, imaging software vendors are differentiating on breadth of anatomical segmentation, pediatric indications, and integration pathways into native viewers and practice software. This not only elevates clinical documentation and patient education, but also positions AI as a standard feature embedded in imaging platforms and data repositories. In materials, leading ceramics portfolios continue to publish long-term evidence and to release new finishing systems that reduce steps and enable one-firing esthetics-important for labs under technician capacity strain and for clinicians seeking reliable, efficient chairside results. Simultaneously, strategic collaborations between materials leaders and 3D-printing specialists are moving permanent, same-day restorations closer to mainstream clinical use, creating a new competitive arena where validated workflows and service support will likely be decisive. Distribution and channel strategy are also in flux. Large distributors have emphasized business continuity, cybersecurity resilience, and digital procurement experiences after prior-year disruptions, while securing multi-year agreements with major DSOs to align equipment, service, and software footprints. A separate storyline involves capital partnerships and governance changes at top distributors, which may catalyze further investment in analytics, automation, and customer success programs. For manufacturer sales leaders, these moves reaffirm that omnichannel excellence-combining field service with robust e-commerce and direct education-will set the pace. Among implant leaders, sustained demand in North America and portions of APAC is being balanced against policy-driven price dynamics in China, where volume-based procurement has reset market structure even as it expands access. Partnerships that link implant systems with scanning and aligner ecosystems indicate a broader trend toward comprehensive, end-to-end offerings spanning surgery, prosthetics, and esthetics. Against this backdrop, aligner innovators marked major treatment milestones while navigating demand variability tied to consumer confidence and financing conditions-further evidence that consumer-pay segments are particularly sensitive to macro shocks. Actionable recommendations to navigate technology choices, regulatory complexity, and margin pressure while elevating patient outcomes

Prioritize technology choices that compress time-to-value. When evaluating intraoral scanners, CBCT, or AI-enabled software, pair clinical criteria with workflow mapping and onboarding plans that minimize training time and service disruption. Favor platforms with open, standards-aligned data exchange to protect optionality as your mix of chairside production, lab partnerships, and aligner providers evolves. Where possible, pilot new systems in a single operatory or location to create internal champions and playbooks before broader deployment-then use structured metrics such as case acceptance cycle time, remakes, and imaging retake rates to validate ROI.

Build tariff resilience into procurement and pricing. Incorporate a tariff audit into quarterly supplier business reviews, specifically flagging exposure to tungsten-containing instruments, electronics components, gloves, masks, syringes, and needles. Negotiate origin flexibility and alternate approved manufacturers to switch quickly as rates or exclusions change, and consider staggered-term contracts to avoid resetting your entire formulary at once. Include tariff-pass-through language, but also secure transparency on surcharge triggers to avoid surprises. For equipment, ask vendors to disclose semiconductor or China-origin content where feasible to anticipate cost pressure and lead-time risk. Treat standards and data governance as strategic assets. Require conformance with relevant ADA informatics standards in RFPs for imaging, practice management, and design software, and insist on clinical data portability to reduce vendor lock-in. Establish role-based access controls and audit trails before expanding AI use, particularly when pediatric indications are in scope or when sharing datasets with third parties for training. Tighten cybersecurity expectations for connected equipment, and integrate imaging devices into patch-management programs, recognizing that many CBCT and scanner platforms now rely on frequent software updates. Strengthen infection-control assurance while adapting to environmental rules. Re-validate reprocessing workflows for handpieces and reusable devices against current CDC and FDA guidance, and communicate these steps to patients as part of quality messaging. For supply teams, monitor sterilizer market updates and factor the EPA's EtO rules into buffer-stock and supplier-selection decisions, especially for disposables that rely on contract sterilization. Align vendor scorecards to include environmental compliance roadmaps and contingency planning. Align regional playbooks with policy. In EMEA, accelerate the transition away from amalgam and confirm MDR readiness for all high-use items; where derogations or legacy device timelines apply, track certificate milestones with your vendors to avoid gaps. In APAC, calibrate implant and aligner forecasts to local reimbursement, VBP, and demand signals; in North America, optimize pricing and financing options for consumer-pay services to buffer macro swings. Across regions, partner with distributors and manufacturers that can commit to uptime, training, and analytics support rather than point products alone. Methodology grounded in triangulated primary insights, regulatory analysis, and technology scanning to ensure decision-grade rigor

This executive summary is grounded in a triangulated methodology designed for decision-grade rigor. The core evidence base combines primary inputs-interviews and briefings with product leaders, clinicians, and procurement executives-with secondary research spanning regulatory notices, standards updates, and verified company disclosures. Particular emphasis was placed on changes effective in 2024-2025 that materially alter product strategy, purchasing, or compliance, including Section 301 tariff adjustments and EPA actions on ethylene oxide; the research reflects official releases and legal analyses to ensure accuracy and timeliness. Technology trends were evaluated using a mixed method: we assessed FDA clearances for AI in dental imaging and reviewed major product launches across scanning and CBCT portfolios to understand feature trajectories, while standards and interoperability assessments drew on ADA informatics resources and technical reports. Where vendor claims were involved, we favored announcements corroborated by multiple sources or by demonstrations at major scientific and trade venues. Regional analysis prioritized policy signals and credible economic sentiment indicators over speculative forecasts. In EMEA, that meant referencing EU regulations on amalgam and MDR transitions; in APAC, assessing China's volume-based procurement effects via executive commentary and sales disclosures; and in the Americas, incorporating Health Policy Institute snapshots of practice conditions. All statements have been checked against their sources as of November 5, 2025, and the synthesis avoids market sizing or share estimates to maintain focus on qualitative and operationally actionable insights. Conclusion: a digital-first decade begins as quality, access, and resilience define leadership in dental equipment and consumables

The next decade in dentistry will be defined by leaders who translate digital capability into reliable, patient-centered value while navigating tighter regulatory and cost constraints. AI has crossed a threshold from novelty to necessity in imaging and case communication; cloud-first scanners and connected CBCT systems are compressing clinical cycles; and materials science is enabling esthetics and durability that meet consumer expectations for natural results, often in a single visit. These are not separate stories-they are the same story seen through different lenses: interoperable data, validated workflows, and disciplined execution.

At the same time, the environment is undeniably more complex. Tariffs are a persistent variable in cost of goods; environmental rules demand resilient sterilization supply chains; and workforce realities require simpler, more trainable systems backed by robust service and education. In Europe, the amalgam phase-out and MDR timelines are durable signals that will shape portfolios and procurement; in Asia-Pacific, procurement policy is widening the implant patient pool; and in the Americas, margin pressure is sharpening the focus on ROI and uptime. The organizations that win will align product, procurement, and people strategies to this reality-using standards to keep options open, partnerships to extend capabilities, and metrics to prove that new technology is performing in the hands of real teams treating real patients.

In short, the industry has moved beyond debating if digital matters to the more productive work of defining how to deploy it responsibly, inclusively, and profitably. Those who act decisively now-choosing interoperable platforms, insulating supply risk, and investing in skills-will find themselves not only better protected against shocks but also positioned to deliver the kind of outcomes that patients increasingly expect and that regulators and payers increasingly reward.

Product Code: MRR-4348D129F9F6

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Porter's Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
- 4.5.1. Near-Term Market Outlook (0-2 Years)
- 4.5.2. Medium-Term Market Outlook (3-5 Years)
- 4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Dental Equipment & Consumables Market, by Product Type

8.1. Dental Consumables
- 8.1.1. Dental Implants
  - 8.1.1.1. Endosteal Implants
  - 8.1.1.2. Subperiosteal Implants
- 8.1.2. Endodontic Products
  - 8.1.2.1. Files & Broaches
  - 8.1.2.2. Obturators
  - 8.1.2.3. Sealers
- 8.1.3. Orthodontic Products
  - 8.1.3.1. Archwires
  - 8.1.3.2. Brackets
8.2. Dental Equipment
- 8.2.1. Diagnostic Equipment
  - 8.2.1.1. Dental Lasers
  - 8.2.1.2. Digital Imaging Systems
  - 8.2.1.3. Intraoral Scanner
- 8.2.2. General Equipment
  - 8.2.2.1. Casting Machines
  - 8.2.2.2. Furnaces
  - 8.2.2.3. Model Scanner
  - 8.2.2.4. Milling Machines
- 8.2.3. Therapeutic Equipment
  - 8.2.3.1. Dental Chairs
  - 8.2.3.2. Dental Handpieces
  - 8.2.3.3. Dental Units

9. Dental Equipment & Consumables Market, by Technology

9.1. Digital
9.2. Traditional

10. Dental Equipment & Consumables Market, by Material Type

10.1. Biomaterials
- 10.1.1. Bone Grafts
- 10.1.2. Tissue Scaffolds
10.2. Ceramics
10.3. Metals
10.4. Polymers

11. Dental Equipment & Consumables Market, by Patient Type

11.1. Adult
11.2. Geriatric
11.3. Pediatric

12. Dental Equipment & Consumables Market, by Distribution Channel

12.1. Offline
12.2. Online
- 12.2.1. eCommerce Platform
- 12.2.2. Manufacturer Websites

13. Dental Equipment & Consumables Market, by End User

13.1. Academic & Research Institutes
13.2. Ambulatory Surgical Centers
13.3. Dental Clinics
13.4. Hospitals

14. Dental Equipment & Consumables Market, by Application

14.1. Cosmetic Dentistry
14.2. Endodontics
14.3. Oral Surgery
14.4. Orthodontics
14.5. Periodontics
14.6. Prosthodontics
14.7. Restorative Dentistry

15. Dental Equipment & Consumables Market, by Region

15.1. Americas
- 15.1.1. North America
- 15.1.2. Latin America
15.2. Europe, Middle East & Africa
- 15.2.1. Europe
- 15.2.2. Middle East
- 15.2.3. Africa
15.3. Asia-Pacific

16. Dental Equipment & Consumables Market, by Group

16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO

17. Dental Equipment & Consumables Market, by Country

17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea

18. United States Dental Equipment & Consumables Market

19. China Dental Equipment & Consumables Market

20. Competitive Landscape

20.1. Market Concentration Analysis, 2025
- 20.1.1. Concentration Ratio (CR)
- 20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. 3M Company
20.6. 3Shape A/S
20.7. A-dec, Inc.
20.8. Align Technology, Inc.
20.9. Amann Girrbach by Capvis
20.10. Aseptico, Inc.
20.11. B. Braun SE
20.12. BEGO GmbH & Co. KG
20.13. Biolase, Inc. by MegaGen Implant Co., Ltd.,
20.14. Brasseler USA
20.15. Dentsply Sirona Inc.
20.16. DURR DENTAL SE
20.17. Envista Holdings Corporation
20.18. GC International AG
20.19. Henry Schein, Inc.
20.20. Ivoclar Vivadent AG
20.21. J. Morita Corp.
20.22. Kuraray America, Inc.
20.23. MEDIT Corp.
20.24. Midmark Corporation
20.25. Millennium Dental Technologies, Inc.
20.26. Nobel Biocare Services AG by Danaher Corporation
20.27. Nova Instruments
20.28. Planmeca Group
20.29. Roland DG Corp.
20.30. Straumann Holding AG
20.31. TAKARA BELMONT Corp
20.32. Vatech Global Co., Ltd.
20.33. Yoshida Dental MFG. Co., Ltd.